ELOXX PHARMACEUTICALS, INC. Adjustments to Additional Paid in Capital, Warrant Issued
ELOXX PHARMACEUTICALS, INC. (ELOX) reported Adjustments to Additional Paid in Capital, Warrant Issued of $400.00 thousand for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-06.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2022-03-30
- ELOXX PHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2020-09-30 was $0.00.
- ELOXX PHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2019-12-31 was $21.00K.
- ELOXX PHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2019-09-30 was $0.00.
- ELOXX PHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2019-06-30 was -$21.00K.
- ELOXX PHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2019 was $421.00K.
- ELOXX PHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2010 was -$1.76M.
- ELOXX PHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2005 was -$1.72M.
- ELOXX PHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2004 was -$2.10M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|---|
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $400.00K 10-Q · filed 2020-11-06 | ||
| 2020-06-30 | $400.00K 10-Q · filed 2020-08-07 | |||
| 2019-12-31 | $21.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $21.00K derived: sum of 2 quarters · filed 2022-03-30 | $0.00 derived: sum of 3 quarters · filed 2022-03-30 | $421.00K 10-K · filed 2022-03-30 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | -$21.00K derived: sum of 2 quarters · filed 2019-11-06 | $400.00K 10-Q · filed 2019-11-06 | |
| 2019-06-30 | -$21.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $400.00K 10-Q · filed 2019-08-07 | ||
| 2019-03-31 | $421.00K 10-Q · filed 2020-11-06 | |||
| 2010-06-30 | -$1.76M 10-K · filed 2013-09-11 | |||
| 2005-06-30 | -$1.72M 10-K · filed 2013-09-11 | |||
| 2004-06-30 | -$2.10M 10-K · filed 2013-09-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |